HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase
September 12, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards
September 11, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
September 07, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Distribution Agreement with FJ Medical, Denmark
August 31, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation
August 24, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio
August 17, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
July 27, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
July 19, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences to Participate at the Inaugural EF Hutton Global Conference
May 08, 2023 08:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference
May 02, 2023 08:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 02, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a next-generation, AI ECG medical...